Impact of Anti-TNFalpha Antibodies on the Risk of Covid-19 and its Severity in Patients with Inflammatory Bowel Diseases. Tursi A, Papa A. J Crohns Colitis 2020;14:1646-1647.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Tursi A, Papa A. Impact of Anti-TNFalpha Antibodies on the Risk of Covid-19 and its Severity in Patients with Inflammatory Bowel Diseases. J Crohns Colitis 2020;14:1646-1647.
PMID: 32303756